Studie (pro)

Alle Studies

TULIP

12 april 2021
A multi-centre, open-label, randomized clinical trial comparing the efficacy and safety of the antibody-drug conjugate SYD985 to physician’s choice in patients with HER2-positive unresectable locally advanced or metastatic...
Bekijken

Vascular fingerprint

12 april 2021
Vascular fingerprint to identify patients at risk for arterial cardiovascular events within the first year after start of cisplatin-based chemotherapy for testicular cancer: a validation study. METc nummer:...
Bekijken

VOICE

6 mei 2021
Vaccination against cOvid In CancEr Protocol nummer: 202000865 METc nummer: 2020/588 Samenvatting Vaccinatie tegen het coronavirus is een standaardbehandeling en is onderdeel van het rijksvaccinatieprogramma. Binnen de VOICE...
Bekijken

VOLGA

3 februari 2022
Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin...
Bekijken

VULCANize-II

4 april 2024
PRIMARY CHEMORADIATION VERSUS NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY AS TREATMENT STRATEGY FOR LOCALLY ADVANCED VULVAR CARCINOMA (LVAC) Samenvatting De VULCANize2-studie is een studie waarbij patiënten met LAVC die...
Bekijken

ZEJULA/Pass studie Niraparib

12 april 2021
Post-authorization safety study to evaluate the risks of myelodysplastic syndrome/acute myeloid leukemia and second primary malignancies in adult patients with platinum-sensitive, relapsed, high-grade serous epithelial ovarian, fallopian tube,...
Bekijken

ZEPHIR

A phase II prospective imaging study evaluating the utility of pre-treatment zirconium-89 labelled trastuzumab PET/CT and an early FDG-PET/CT response to identify patients with advanced HER-2 positive breast...
Bekijken